This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignee: H Bion Co., Ltd.. Active years: 2014-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2016
Title: Eul-Soon Park: Innovator in Stem Cell Research
Introduction
Eul-Soon Park is a prominent inventor based in Chungcheongbuk-do, South Korea. He has made significant contributions to the field of stem cell research, particularly in the development of embryonic stem cell lines. With a total of 2 patents, his work has the potential to impact various medical applications.
Latest Patents
Eul-Soon Park's latest patents include groundbreaking innovations in stem cell technology. One of his patents focuses on a neuro-progenitor produced from an SCNT-derived embryonic stem cell. This embryonic stem cell line is derived from a nucleus-transferred oocyte, which is prepared by transferring a nucleus of a human somatic cell into an enucleated human oocyte. This innovative approach allows for differentiation into various desired cell types. Another patent details a human embryonic stem cell line prepared by the same nuclear transfer method, emphasizing its potential to differentiate into multiple cell types.
Career Highlights
Eul-Soon Park is associated with H Bion Co., Ltd., where he continues to advance his research in stem cell technology. His work is recognized for its potential to revolutionize regenerative medicine and therapeutic applications.
Collaborations
Eul-Soon Park has collaborated with notable researchers in the field, including Sung-Il Roh and Woo-Suk Hwang. These collaborations have further enhanced the impact of his research and innovations.
Conclusion
Eul-Soon Park is a key figure in the realm of stem cell research, with a focus on developing innovative embryonic stem cell lines. His contributions are paving the way for future advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile